Therapeutic Regimens in Acute Experimental Hemorrhagic Pancreatitis
- 1 December 1988
- journal article
- research article
- Published by Elsevier in Gastroenterology
- Vol. 95 (6) , 1648-1657
- https://doi.org/10.1016/s0016-5085(88)80091-x
Abstract
No abstract availableThis publication has 40 references indexed in Scilit:
- Gabexate Mesilate (FOY) Protects Against Ceruletide-Induced Acute Pancreatitis in the RatPancreas, 1987
- Beneficial effects of cholecystokinin-receptor blockade and inhibition of proteolytic enzyme activity in experimental acute hemorrhagic pancreatitis in mice. Evidence for cholecystokinin as a major factor in the development of acute pancreatitis.Journal of Clinical Investigation, 1986
- Pharmacological Studies of FUT-175, Nafamostat Mesilate V. Effects on the Pancreatic Enzymes and Experimental Acute Pancreatitis in RatsThe Japanese Journal of Pharmacology, 1986
- Enzyme transfer from pancreas to plasma during acute pancreatitis. The contribution of ascitic fluid and lymphatic drainage of the pancreas.Gut, 1985
- Acute pancreatitis: a lethal disease of increasing incidence.Gut, 1985
- Controlled Clinical Trial of Peritoneal Lavage for the Treatment of Severe Acute PancreatitisNew England Journal of Medicine, 1985
- Effect of a Specific Serine Protease Inhibitor on the Rat Pancreas: Systemic Administration of Camostate and Exocrine Pancreatic SecretionDigestion, 1984
- Beneficial effect of pancreatic polypeptide in experimental pancreatitisDigestive Diseases and Sciences, 1983
- Complement activation and complement control proteins in acute pancreatitis.Gut, 1982
- Continuous peritoneal dialysis as treatment of acute experimental pancreatitis in the ratDigestive Diseases and Sciences, 1979